Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.52 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.48 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.45 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylamine SCHEMBL27926648 | 0.95 | CYP4F2 (0.48) | GABRA1GABRB2CYP4F2CYP4A11APOBEC3G | |
| Phenol SCHEMBL28220962 | 0.89 | GABRA1 (0.48) | GABRA1GABRB2CYP4F2CYP4A11APOBEC3G | |
| Hydrogen Peroxide SCHEMBL11205186 | 0.85 | GABRA1 (0.60) | GABRA1GABRB2MGLLGAAMAPT | |
| Hydrogen Peroxide SCHEMBL10890655 | 0.85 | GABRA1 (0.60) | GABRA1GABRB2MGLLGAAMAPT | |
| SCHEMBL25425763 | 0.85 | GABRA1 (0.58) | GABRA1GABRB2MGLLGAAMAPT | |
| SCHEMBL41139 | 0.85 | APOBEC3G (0.60) | CYP4F2CYP4A11APOBEC3GPDCD1CD274 | |
| SCHEMBL29366632 | 0.85 | APOBEC3G (0.60) | CYP4F2CYP4A11APOBEC3GPDCD1CD274 | |
| SCHEMBL36294 | 0.85 | GABRA1 (0.58) | GABRA1GABRB2MGLLGAAMAPT | |
| SCHEMBL29390847 | 0.85 | GABRA1 (0.58) | GABRA1GABRB2MGLLGAAMAPT | |
| Propanol SCHEMBL29070931 | 0.83 | GABRA1 (0.52) | GABRA1GABRB2CYP4F2CYP4A11MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 585 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122095027-A | Modified maleated natural oil-based reaction products and slurry compositions containing the same | — | 2026-05-26 | — | — | CN | claimed |
| CN-122055416-A | Dispersants for carbon nanotubes and carbon nanotube compositions comprising hydrophobically and hydrophilically modified maleated natural oil salts | 埃斯普投资有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4704575-A2 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS AND ITS AGRICULTURAL COMPOSITIONS AND METHODS OF USE | ISP Investments LLC (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4683973-A2 | DISPERSANT COMPOSITIONS COMPRISING HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, AND APPLICATIONS THEREOF | ISP Investments LLC (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4683510-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND AGRICULTURAL COMPOSITIONS THEREOF | ISP Investments LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-20260002090-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP INVESTMENTS LLC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4532608-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP Investments LLC (US) | 2025-04-09 | — | — | EP | claimed |
| CN-119677813-A | Hydrophobically modified and hydrophilically modified maleated natural oils and compositions thereof | 埃斯普投资有限公司 | 2025-03-21 | — | — | CN | claimed |
| WO-2025059043-A1 | A MODIFIED MALEATED NATURAL OIL CONTAINING A LACTAM MOIETY, SALTS, COMPOSITIONS, AND USE THEREOF | ISP INVESTMENTS LLC (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2025059020-A1 | DISPERSANT COMPRISING MODIFIED MALEATED NATURAL OIL CONTAINING A LACTAM MOIETY, SALTS FOR CARBON NANOTUBES AND CARBON NANOTUBE COMPOSITION | ISP INVESTMENTS LLC (US) | 2025-03-20 | — | — | WO | claimed |
| EP-1425329-A1 | PROCESS FOR REDUCING RESIDUAL ISOCYANATE | 3M Innovative Properties Company (US) | 2004-06-09 | — | — | EP | claimed |
| US-6664414-B2 | Using quenching agents which is reaction product of phenolic alcohol and organosilicon compound | 3M INNOVATIVE PROPERTIES COMPANY | 2003-12-16 | — | — | US | claimed |
| US-20030092932-A1 | Process for reducing residual isocyanate | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-15 | — | — | US | claimed |
| WO-2003022901-A1 | PROCESS FOR REDUCING RESIDUAL ISOCYANATE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-03-20 | — | — | WO | claimed |
| EP-1029149-A4 | VISCOELASTIC SURFACTANT FRACTURING FLUIDS AND A METHOD FOR FRACTURING SUBTERRANEAN FORMATIONS | WHALEN ROBERT T (US) | 2001-02-07 | — | — | EP | claimed |
| EP-1029149-A1 | VISCOELASTIC SURFACTANT FRACTURING FLUIDS AND A METHOD FOR FRACTURING SUBTERRANEAN FORMATIONS | Whalen, Robert T. (US) | 2000-08-23 | — | — | EP | claimed |
| US-6035936-A | PUMPING SURFACTANT MIXTURE INTO WELL | WHALEN ROBERT T (US) | 2000-03-14 | — | — | US | claimed |
| WO-1999024693-A1 | VISCOELASTIC SURFACTANT FRACTURING FLUIDS AND A METHOD FOR FRACTURING SUBTERRANEAN FORMATIONS | WHALEN ROBERT T (US) | 1999-05-20 | — | — | WO | claimed |
| EP-0098701-A1 | Process for hydroxylating olefins in the presence of an osmium oxide catalyst and carboxylate salt co-catalyst | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-01-18 | — | — | EP | claimed |
| US-4123330-A | Color diffusion transfer process using benzyl alcohol and derivatives thereof | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1978-10-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092932-A1 | Process for reducing residual isocyanate | ALKBH3, ALKBH2, TET2 | GABRA1 1716/4885GABRB2 1730/4885CYP4F2 844/4885 |
| US-20260002090-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | CUTA, KRT18, HACD3 | GABRA1 2933/4885GABRB2 3684/4885CYP4F2 1480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.